Multiple Sclerosis Clinical Trial
Official title:
Feasibility, Validity and Reliability Kinematic Movement Analysis of Upper Limb Movements in Stroke and MS Patients Using Inertial Sensors
Verified date | December 2018 |
Source | Hasselt University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study has 3 aimes:
1. To investigate the feasibility of using IMUs (Xsens, MVN Studio) during functional tasks
to assess upper limb kinematics in pwMS and stroke survivors. On the one hand, the
feasibility of performing the tasks will be investigated . On the other hand, does the
XSens give valuable data?
2. To investigate the discriminative validity of kinematic measurements of upper limb
movements post-stroke and pwMS in comparison with gender and age-matched healthy
controls
3. To investigate the test-retest reliability of the kinematic parameters collected during
the different functional tasks in pwMS and stroke survivors
It is a cross-sectional case-controlled observational study, with 3 different groups: 25
Persons with Multiple sclerosis, 25 stroke patients and 50 healthy controls, matched by age
and gender.
Status | Completed |
Enrollment | 18 |
Est. completion date | May 31, 2018 |
Est. primary completion date | May 31, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: Inclusion criteria for all participants: Healthy controls, pwsMS and stroke patients - No orthopedic or neuro-muscular impairments in the upper limb - Age > 18 years - Able to understand and execute the test instructions - Perceived pain in one of the upper limbs of more than 4/10 (Visual Analog Scale) - Able to move a joint (wrist, elbow or shoulder) in the upper limb against gravity without resistance (Medical Research Council) (16). Inclusion criteria for PwMS: - Diagnosed with MS using McDonald criteria (17) Inclusion criteria Stroke patients - First- ever single, unilateral (ischemic or hemorrhagic) - At least one month after stroke - No apraxia or hemi spatial neglect Exclusion Criteria: Exclusion Criteria for pwMS only: - a relapse 3 months before the start of the study - A change of symptomatic medication during the testing period Exclusion Criteria: - People with predominantly ataxia or tremor are excluded from the reliability part of this study |
Country | Name | City | State |
---|---|---|---|
Belgium | Jessa Ziekenhuis | Hasselt | |
Belgium | Revalidatie & MS Centrum Overpelt | Overpelt |
Lead Sponsor | Collaborator |
---|---|
Hasselt University | Jessa Hospital, Revalidatie & MS Centrum Overpelt |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | kinematic parameter | The data received of the IMU's are the angles of point task achievement (PTA). PTA is defined as the instant when the ROM, needed for successful task execution, was achieved. Different joint angles of PTA will be calculated by MVN BIOMECH software. Matlab (software version R2016b) and excel will be used to process the data. | day 2 | |
Primary | kinematic parameter | The data received of the IMU's are the angles of point task achievement (PTA). PTA is defined as the instant when the ROM, needed for successful task execution, was achieved. Different joint angles of PTA will be calculated by MVN BIOMECH software. Matlab (software version R2016b) and excel will be used to process the data. | day 3 | |
Secondary | The Brunnström Fugl Meyer (BFM) | The Brunnström Fugl Meyer (BFM) was used to measure motor control at the body functions and structures level. The upper limb section is applied: shoulder, elbow, forearm, wrist movements and grip | day 1 | |
Secondary | Action Research arm test | which assessed the patient's ability to handle objects varying in size | Day 1 | |
Secondary | Trunk Impairment Scale | To examine the clinimetric characteristics of the Trunk Impairment Scale (TIS). This scale evaluates motor impairment of the trunk after stroke. The TIS scores, on a range from 0 to 23, static and dynamic sitting balance as well as trunk co-ordination. It also aims to score the quality of trunk movement and to be a guide for treatment. | day 1 | |
Secondary | Manual Ability Measure-36 (questionnaire) | Perceived performance on activity level | day1 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |